Clinical Trial Update: Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing efficacy, pharmacokinetic interactions, and safety of dolutegravir with two NRTIs in HIV-1–infected solid organ transplant recipients; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Solid Organ Transplantation

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: HIV-1-infection, Solid Organ Transplant | Phase 4 | Status: COMPLETED | Results posted: 2025-09-30